Can This Beaten-Down Stock Bounce Back in 2025?
However, Pfizer's revenue guidance for 2025 doesn't look particularly exciting. The company expects its top line to come in ...
stockhead55m
High Voltage: Trump throws out EV mandate in lithium blow, but US rare earths still on agenda
On Monday the company closed a US$996 million ($1.6bn) loan, including US$968m in principal and US$28m of capitalised interest, a US$268m mark up from a conditional loan announced for its Rhyolite ...